400-93-1Relevant articles and documents
Profiling the interaction of a novel toxic pyruvate dehydrogenase kinase inhibitor with human serum albumin
Liao, Xianjiu,Zhu, Chunlei,Huang, Ding,Wen, Xiaoqing,Zhang, Shao-Lin,Shen, Yizhong
, (2021)
To discover novel pyruvate dehydrogenase kinase (PDK) inhibitors, a new compound 2,2-dichloro-1-(4-((4-isopropylphenyl)amino)-3-nitrophenyl)ethan-1-one, namely XB-1 was identified, which inhibited PDK activity with a half maximal inhibitory concentration
Semicarbazone compounds and application thereof
-
Paragraph 0096-0098, (2020/07/13)
The invention belongs to the technical field of medicines, and relates to semicarbazone compounds as shown in a general formula I and pharmaceutically acceptable salts, hydrates or prodrugs thereof, wherein the definitions of substituent groups R1, R2, R3
Thiazole derivative compounds having IDO inhibitory activity, preparation method and application thereof
-
Paragraph 0045; 0050-0052, (2019/01/13)
The invention relates to the technical field of medicinal chemistry, in particular to thiazole derivative compounds having IDO (indoleamine-2,3-dioxygenase) inhibitory activity, a preparation method and application thereof. The invention discloses thiazol